Recombinant human parathyroid hormone (Beijing ShuangLu Pharmaceutical)

重组人甲状旁腺激素（双鹭药业）

Report date: 2022/06/27 20:00:35

Base Information

Drug NameRecombinant human parathyroid hormone (Beijing ShuangLu Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone receptor agonistsOsteogenesis stimulantsCalcium sensing receptor antagonists +[4] 
TargetsCalcium sensing receptorParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sl Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A